Dexterra Valuation
| DXT Stock | CAD 6.97 0.07 0.99% |
At this time, the firm appears to be fairly valued. Dexterra Group shows a prevailing Real Value of C$6.75 per share. The current price of the firm is C$6.97. Our model computes the value of Dexterra Group from reviewing the firm fundamentals such as Profit Margin of 0.01 %, shares outstanding of 63.82 M, and Current Valuation of 568.8 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Dexterra's valuation include:
Price Book 1.5969 | Enterprise Value 568.8 M | Enterprise Value Ebitda 6.0848 | Price Sales 0.3821 | Forward PE 10.0604 |
Fairly Valued
Today
Please note that Dexterra's price fluctuation is not too volatile at this time. Calculation of the real value of Dexterra Group is based on 3 months time horizon. Increasing Dexterra's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Dexterra is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dexterra Stock. However, Dexterra's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.97 | Real 6.75 | Hype 6.96 |
The intrinsic value of Dexterra's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dexterra's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Dexterra Group helps investors to forecast how Dexterra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dexterra more accurately as focusing exclusively on Dexterra's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Dexterra's intrinsic value based on its ongoing forecasts of Dexterra's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Dexterra's closest peers.
Dexterra Cash |
|
Dexterra Valuation Trend
Knowing Dexterra's actual value is paramount for traders when making sound investment determinations. Using both Dexterra's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Dexterra Total Value Analysis
Dexterra Group is currently anticipated to have takeover price of 568.8 M with market capitalization of 449.32 M, debt of 117.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dexterra fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
568.8 M | 449.32 M | 117.3 M |
Dexterra Investor Information
About 52.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. Dexterra Group has Price/Earnings To Growth (PEG) ratio of 0.61. The entity last dividend was issued on the 31st of December 2024. The firm had 1:5 split on the 16th of July 2020. Based on the key measurements obtained from Dexterra's financial statements, Dexterra Group is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 55.2 M | 66.1 M |
|
|
Dexterra Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dexterra has an asset utilization ratio of 184.03 percent. This suggests that the Company is making C$1.84 for each dollar of assets. An increasing asset utilization means that Dexterra Group is more efficient with each dollar of assets it utilizes for everyday operations.Dexterra Ownership Allocation
Dexterra holds a total of 63.82 Million outstanding shares. Dexterra Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Dexterra Profitability Analysis
The company reported the revenue of 1.12 B. Net Income was 26.62 M with profit before overhead, payroll, taxes, and interest of 90.55 M.Dexterra Past Distributions to stockholders
About Dexterra Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Dexterra Group. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Dexterra Group based exclusively on its fundamental and basic technical indicators. By analyzing Dexterra's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Dexterra's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dexterra. We calculate exposure to Dexterra's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dexterra's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 99.9 M | 58 M | |
| Pretax Profit Margin | 0.03 | 0.03 | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Profit Margin | 0.02 | 0.03 | |
| Gross Profit Margin | 0.13 | 0.07 |
Dexterra Quarterly Retained Earnings |
|
Other Information on Investing in Dexterra Stock
Dexterra financial ratios help investors to determine whether Dexterra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dexterra with respect to the benefits of owning Dexterra security.